Susceptibility to 11 antibiotics was determined for 63 cultures of Staphylococcus aureus and 63 cultures of Staphylococcus epidermidis obtained at random from the clinical laboratory. The incidence of resistance to nine of these antibiotics was greater for S. epidermidis than for S. aureus. Studies of the minimal inhibitory concentration of these cultures to clindamycin showed that 61 cultures of S. aureus were susceptible whereas only 46 cultures of S. epidermidis were susceptible to this antibiotic. Although cultures of S. aureus were more active in the production of seven virulence factors, some cultures of S. epidermidis produced virulence factors. By successive cultivation in increasing concentrations of clindamycin, resistant variants were obtained for 10 cultures of S. aureus and 3 cultures of S. epidermidis. The presence of subinhibitory concentrations of clindamycin inhibited the production of some virulence factors by the resistant variants. In view of the greater resistance of S. epidermidis to antibiotics and its ability to produce virulence factors, its isolation in the clinical laboratory should not be regarded lightly.
The role of Staphylococcus epidermidis in serious infections has drawn relatively little attention since coagulase-positive staphylococci are isolated more frequently from pyogenic infections. Increased interest in S. epidermidis has resulted, however, from the increasing frequency of isolation of antibioticresistant, coagulase-negative staphylococci from infections (2) . The purpose of this study was to compare the antibiotic susceptibility and the production of virulence factors by cultures of Staphylococcus aureus and S. epidermidis. We also report the effects of the in vitro development of resistance to clindamycin on the subsequent production of virulence factors by cultures grown either in the presence or fermentation of mannitol, and the aerobic and anaerobic utilization of dextrose were used to confirm the classification of organisms. The production of coagulase was used to distinguish the two species. Antibiograms were determined by the Kirby-Bauer method (3) with Mueller-Hinton agar (BBL) and the following high-potency antibiotic discs (BBL): ampicillin, chloramphenicol, clindamycin, erythromycin, lincomycin, methicillin, nafcillin, neomycin, penicillin, tetracycline, and triacetyloleandomycin.
To obtain clindamycin-resistant variants, 10 susceptible cultures of S. aureus and 3 susceptible cultures of S. epidermidis were cultivated successively at 37 C in Trypticase soy broth (TSB; BBL) containing clindamycin (Cleocin, Upjohn Co.) which increased in serial twofold concentrations ranging from 0.015 gg/ml to 100 jg/ml. When the turbidity in the last tube showing growth was equivalent to the turbidity standard used in the Kirby-Bauer disk diffusion method (3), 0.1 ml was removed and used to inoculate the tube with the next higher concentration of antibiotic. This procedure was continued until the organism was incapable of growing in the next higher concentration of clindamycin or growth in a concentration of 100 Ag/ml was achieved. The minimal inhibitory concentration (MIC) of clindamycin for either the susceptible parent or resistant variant was determined in TSB containing clindamycin according to the method of Griffith (10) . The MIC was read as the lowest concentration of clindamycin that prevented development of visible growth after 24 hr at 37 C.
The production of lipase (16) , phosphatase (16), protease (15) and deoxyribonuclease (deoxyribonuclease agar, Fisher) was determined. The method of Abramson and Friedman (1) was used for the determination of alpha, beta, and delta hemolysins. Cultures were grown in TSB for 18 to 24 hr at 37 C, and hemolysin activity was determined with the supernatant fluids of centrifuged cultures and washed rabbit, sheep, or human erythrocytes. To determine the effects of clindamycin on the production of virulence factors by clindamycin-resistant variants, a sub nhibitory concentration (generally 2 jg/ml) of clindamycin which permitted confluent growth in 18 to 24 hr was added to each of the test media. Cultures tested on media containing no antibiotic were grown in TSB containing antibiotic, centrifuged, and resuspended in TSB lacking antibiotic before being inoculated onto the test media. To test for hemolysin activity, the clindamycin-resistant variants were grown in the presence and absence of clindamycin in TSB, and the supernatant fluids of centrifuged cultures were tested for lysis of washed rabbit, sheep, or human erythrocytes.
RESULTS
The number and percentage of antibioticresistant cultures among the 63 cultures of S. aureus and S. epidermidis are shown in Table 1 . A greater number of cultures of S. epidermidis were resistant to antibiotics than cultures of S. aureus. The MIC of 61 cultures of S. aureus susceptible to clindamycin varied from less than 0.2 Mg/ml to less than 0.5 Mg/ml, whereas two cultures were resistant to greater than 100 Mg/ml. The MIC of 46 cultures of S. epidermidis susceptible to clindamycin varied from less than 0.1 ug/ml to less than 0.5 yg/ml. One culture was inhibited by less than 2.0 gg/ ml and one by less than 20.0 ,g/mi, and 15 were resistant to greater than 100 Mg/ml. After 14 serial transfers in clindamycin, 9 of 10 hibitory concentrations of clindamycin and tested on media containing this antibiotic or on media lacking this antibiotic, Table 3 shows the production of these same virulence factors by 10 clindamycin-resistant variants of S. aureus and 3 clindamycin-resistant variants of S. epidermidis. With S. aureus, more of the resistant variants lost the capacity to produce the particular virulence factor when tested on media containing clindamycin than when tested on media containing no antibiotic. This was most marked with phosphatase, protease, and the production of hemolysins. With S. epidermidis, loss of the capacity to produce phosphatase or protease on media containing clindamycin was observed for single resistant variants.
DISCUSSION
The results show that the isolation in the clinical laboratory of S. epidermidis either alone or in combination with S. aureus should not be regarded lightly. Although the parameters for the pathogenicity of coagulase-negative staphylococci have not been defined, their resistance to antibiotics makes it imperative that coagulase-negative isolates be tested carefully in the laboratory prior to administration of an antibiotic. As shown in Table 1 , of the 11 antibiotics tested, the incidence of resistance to 9 of these was greater for cultures of S. epidermidis as compared to an identical number (4, 12) and lincomycin-resistant strains (7) by this method. Benner and Adams (4) found that those cultures that develop resistance to lincomycin and clindamycin quickly and to high levels contain within their population small numbers of cells which differ markedly in their drug resistance, and these cells are responsible for the high levels of resistance obtained.
The greater capacity of S. aureus to produce virulence factors was not unexpected (Table 2) . It is generally accepted that the ability of S. aureus to produce disease is not the result of the production of any particular extracellular product but, more likely, results from the production of a combination of virulence factors, not disregarding the resistance of the host (6) . As shown in Table 2 , S. epidermidis is able to produce some of these extracellular products, and this capacity, in addition to their greater resistance to antibiotics, makes them a potential threat when isolated in the clinical laboratory. The production of virulence factors by coagulase-negative staphylococci has been observed by others (1) . Also, it has been reported recently (5) that S. epidermidis spreads more rapidly and to a greater extent than S. aureus, develops a higher level of antibiotic resistance than S. aureus, and resistant strains of S. epidermidis are found more often in both untreated and treated patients. In view of the frequency with which S. epidermidis has been isolated from patients with bacterial endocarditis (8) , infections of the central nervous system (14) , urinary tract infections (13), wound infections (17) , and from patients undergoing surgery (2) , and the more complicated surgical procedures become and the more often prosthetic devices are used, the more imperative it becomes that contamination by S. epidermidis be avoided.
The inhibition of alpha hemolysin production by growth of S. aureus in subinhibitory concentrations of antibiotics whose mode of action is inhibition of protein synthesis was observed by Kobayasi et al. (11) . In our study (Table 3) , clindamycin, an antibiotic which inhibits the function of the 50S ribosomal subunit, had a similar inhibitory effect not only on hemolysin production but also on deoxyribonuclease, phosphatase, and protease production. Whether this alteration in enzymatic and hemolytic activity was due to the action of the antibiotic on ribosomal function or the selection by the antibiotic of an enzymatically inactive population was not determined. The significance of these results in the prevention of tissue destruction in infections caused by the elaboration of toxic products by staphylococci warrants further investigation.
